Thymoquinone Enhances Doxorubicin Efficacy via RAS/RAF Pathway Modulation in Ovarian Adenocarcinoma

Thymoquinone Enhances Doxorubicin Efficacy via RAS/RAF Pathway Modulation in Ovarian Adenocarcinoma

<b>Background/Objectives:</b> Ovarian cancer remains one of the most commonly diagnosed malignancies among women worldwide. The heterogeneity among tumor subtypes and the emergence of treatment resistance have raised significant concerns regarding the long-term efficacy of chemotherapy,...

Full description

Saved in:
Bibliographic Details
Main Authors: Veysel Toprak, İlhan Özdemir, Şamil Öztürk, Orhan Yanar, Yusuf Ziya Kizildemir, Mehmet Cudi Tuncer
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Pharmaceutics
Subjects:
ovarian cancer
apoptosis
thymoquinone
immunofluorescent staining
Online Access:https://www.mdpi.com/1999-4923/17/4/536
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items